MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1021/acs.jmedchem.7b00974

Медицинская библиотека · Journal of medicinal chemistry · 2017

Discovery of a Novel and Selective Indoleamine 2,3-Dioxygenase (IDO-1) Inhibitor 3-(5-Fluoro-1H-indol-3-yl)pyrrolidine-2,5-dione (EOS200271/PF-06840003) and Its Characterization as a Potential Clinical Candidate.

Crosignani Stefano, Bingham Patrick, Bottemanne Pauline, Cannelle Hélène, Cauwenberghs Sandra, Cordonnier Marie, Dalvie Deepak, Deroose Frederik, Feng Jun Li, Gomes Bruno, Greasley Samantha, Kaiser Stephen E, Kraus Manfred, Négrerie Michel, Maegley Karen, Miller Nichol, Murray Brion W, Schneider Manfred, Soloweij James, Stewart Albert E, Tumang Joseph, Torti Vince R, Van Den Eynde Benoit, Wythes Martin

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

Tumors use tryptophan-catabolizing enzymes such as indoleamine 2,3-dioxygenase (IDO-1) to induce an immunosuppressive environment. IDO-1 is induced in response to inflammatory stimuli and promotes immune tolerance through effector T-cell anergy and enhanced Treg function. As such, IDO-1 is a nexus for the induction of a key immunosuppressive mechanism and represents an important immunotherapeutic target in oncology. Starting from HTS hit 5, IDO-1 inhibitor 6 (EOS200271/PF-06840003) has been developed. The structure-activity relationship around 6 is described and rationalized using the X-ray crystal structure of 6 bound to human IDO-1, which shows that 6, differently from most of the IDO-1 inhibitors described so far, does not bind to the heme iron atom and has a novel binding mode. Clinical candidate 6 shows good potency in an IDO-1 human whole blood assay and also shows a very favorable ADME profile leading to favorable predicted human pharmacokinetic properties, including a predicted half-life of 16-19 h.

Для цитирования: Crosignani Stefano, Bingham Patrick, Bottemanne Pauline, Cannelle Hélène, Cauwenberghs Sandra, Cordonnier Marie, Dalvie Deepak, Deroose Frederik, Feng Jun Li, Gomes Bruno, Greasley Samantha, Kaiser Stephen E, Kraus Manfred, Négrerie Michel, Maegley Karen, Miller Nichol, Murray Brion W, Schneider Manfred, Soloweij James, Stewart Albert E, Tumang Joseph, Torti Vince R, Van Den Eynde Benoit, Wythes Martin. Discovery of a Novel and Selective Indoleamine 2,3-Dioxygenase (IDO-1) Inhibitor 3-(5-Fluoro-1H-indol-3-yl)pyrrolidine-2,5-dione (EOS200271/PF-06840003) and Its Characterization as a Potential Clinical Candidate.. Journal of medicinal chemistry. 2017. DOI: 10.1021/acs.jmedchem.7b00974.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.